{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:18:11Z","timestamp":1792639091294,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40478-017-0464-2","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T01:06:17Z","timestamp":1504659977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease"],"prefix":"10.1186","volume":"5","author":[{"given":"J.","family":"Hordeaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Dubreil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Robveille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Deniaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Pascal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Dequ\u00e9ant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pailloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lagalice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ledevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Babarit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Costiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Jamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fusellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Mallem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2105-3094","authenticated-orcid":false,"given":"C.","family":"Ciron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Huchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Caillaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-A","family":"Colle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,6]]},"reference":[{"key":"464_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1586\/eci.12.40","volume":"8","author":"SG Banugaria","year":"2012","unstructured":"Banugaria SG, Patel TT, Kishnani PS (2012) Immune modulation in Pompe disease treated with enzyme replacement therapy. Expert Rev Clin Immunol 8:497\u2013499. doi: 10.1586\/eci.12.40","journal-title":"Expert Rev Clin Immunol"},{"key":"464_CR2","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/gim.2015.6","volume":"17","author":"KL Berrier","year":"2015","unstructured":"Berrier KL, Kazi ZB, Prater SN, Bali DS, Goldstein J, Stefanescu MC, Rehder CW, Botha EG, Ellaway C, Bhattacharya K, Tylki-Szymanska A, Karabul N, Rosenberg AS, Kishnani PS (2015) CRIM-negative infantile Pompe disease: characterization of immune responses in patients treated with ERT monotherapy. Genet Med 17:912\u2013918. doi: 10.1038\/gim.2015.6","journal-title":"Genet Med"},{"key":"464_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1089\/hum.2012.218","volume":"24","author":"T Bucher","year":"2013","unstructured":"Bucher T, Colle MA, Wakeling E, Dubreil L, Fyfe J, Briot-Nivard D, Maquigneau M, Raoul S, Cherel Y, Astord S, Duque S, Marais T, Voit T, Moullier P, Barkats M, Joussemet B (2013) scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease. Hum Gene Ther 24:670\u2013682. doi: 10.1089\/hum.2012.218","journal-title":"Hum Gene Ther"},{"key":"464_CR4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/gt.2014.16","volume":"21","author":"T Bucher","year":"2014","unstructured":"Bucher T, Dubreil L, Colle MA, Maquigneau M, Deniaud J, Ledevin M, Moullier P, Joussemet B (2014) Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats. Gene Ther 21:522\u2013528. doi: 10.1038\/gt.2014.16","journal-title":"Gene Ther"},{"key":"464_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.pediatrneurol.2010.02.006","volume":"42","author":"TA Burrow","year":"2010","unstructured":"Burrow TA, Bailey LA, Kinnett DG, Hopkin RJ (2010) Acute progression of neuromuscular findings in infantile Pompe disease. Pediatr Neurol 42:455\u2013458. doi: 10.1016\/j.pediatrneurol.2010.02.006","journal-title":"Pediatr Neurol"},{"key":"464_CR6","doi-asserted-by":"publisher","first-page":"R61","DOI":"10.1093\/hmg\/ddr174","volume":"20","author":"BJ Byrne","year":"2011","unstructured":"Byrne BJ, Falk DJ, Pacak CA, Nayak S, Herzog RW, Elder ME, Collins SW, Conlon TJ, Clement N, Cleaver BD, Cloutier DA, Porvasnik SL, Islam S, Elmallah MK, Martin A, Smith BK, Fuller DD, Lawson LA, Mah CS (2011) Pompe disease gene therapy. Hum Mol Genet 20:R61\u2013R68. doi: 10.1093\/hmg\/ddr174","journal-title":"Hum Mol Genet"},{"key":"464_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2011.02.004","volume":"103","author":"BJ Byrne","year":"2011","unstructured":"Byrne BJ, Kishnani PS, Case LE, Merlini L, Muller-Felber W, Prasad S, van der Ploeg A (2011) Pompe disease: design, methodology, and early findings from the Pompe registry. Mol Genet Metab 103:1\u201311. doi: 10.1016\/j.ymgme.2011.02.004","journal-title":"Mol Genet Metab"},{"key":"464_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1089\/humc.2014.2514","volume":"25","author":"PI Byrne","year":"2014","unstructured":"Byrne PI, Collins S, Mah CC, Smith B, Conlon T, Martin SD, Corti M, Cleaver B, Islam S, Lawson LA (2014) Phase I\/II trial of diaphragm delivery of recombinant adeno-associated virus acid alpha-glucosidase (rAAaV1-CMV-GAA) gene vector in patients with Pompe disease. Hum Gene Ther Clin Dev 25:134\u2013163. doi: 10.1089\/humc.2014.2514","journal-title":"Hum Gene Ther Clin Dev"},{"key":"464_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1755-8417-1-6","volume":"1","author":"M Cardone","year":"2008","unstructured":"Cardone M, Porto C, Tarallo A, Vicinanza M, Rossi B, Polishchuk E, Donaudy F, Andria G, De Matteis MA, Parenti G (2008) Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts. PathoGenetics 1:6. doi: 10.1186\/1755-8417-1-6","journal-title":"PathoGenetics"},{"key":"464_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.nmd.2011.01.005","volume":"21","author":"M Carre-Pierrat","year":"2011","unstructured":"Carre-Pierrat M, Lafoux A, Tanniou G, Chambonnier L, Divet A, Fougerousse F, Huchet-Cadiou C, Segalat L (2011) Pre-clinical study of 21 approved drugs in the mdx mouse. Neuromuscul Disord 21:313\u2013327. doi: 10.1016\/j.nmd.2011.01.005","journal-title":"Neuromuscul Disord"},{"key":"464_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ajmg.c.31321","volume":"160C","author":"LE Case","year":"2012","unstructured":"Case LE, Beckemeyer AA, Kishnani PS (2012) Infantile Pompe disease on ERT: update on clinical presentation, musculoskeletal management, and exercise considerations. Am J Med Genet C Semin Med Genet 160C:69\u201379. doi: 10.1002\/ajmg.c.31321","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"464_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/pd.807","volume":"24","author":"CP Chen","year":"2004","unstructured":"Chen CP, Lin SP, Tzen CY, Tsai FJ, Hwu WL, Wang W (2004) Detection of a homozygous D645E mutation of the acid alpha-glucosidase gene and glycogen deposition in tissues in a second-trimester fetus with infantile glycogen storage disease type II. Prenat Diagn 24:231\u2013232. doi: 10.1002\/pd.807","journal-title":"Prenat Diagn"},{"key":"464_CR13","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1194\/jlr.R047175","volume":"55","author":"SH Cheng","year":"2014","unstructured":"Cheng SH (2014) Gene therapy for the neurological manifestations in lysosomal storage disorders. J Lipid Res 55:1827\u20131838. doi: 10.1194\/jlr.R047175","journal-title":"J Lipid Res"},{"key":"464_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1203\/01.pdr.0000233014.84318.4e","volume":"60","author":"YH Chien","year":"2006","unstructured":"Chien YH, Lee NC, Peng SF, Hwu WL (2006) Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy. Pediatr Res 60:349\u2013352. doi: 10.1203\/01.pdr.0000233014.84318.4e","journal-title":"Pediatr Res"},{"key":"464_CR15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/mus.24444","volume":"51","author":"M Corti","year":"2015","unstructured":"Corti M, Smith BK, Falk DJ, Lawson LA, Fuller DD, Subramony SH, Byrne BJ, Christou EA (2015) Altered activation of the tibialis anterior in individuals with Pompe disease: implications for motor unit dysfunction. Muscle Nerve 51:877\u2013883. doi: 10.1002\/mus.24444","journal-title":"Muscle Nerve"},{"key":"464_CR16","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.4161\/hv.21405","volume":"8","author":"LP Cousens","year":"2012","unstructured":"Cousens LP, Mingozzi F, van der Marel S, Su Y, Garman R, Ferreira V, Martin W, Scott DW, De Groot AS (2012) Teaching tolerance: new approaches to enzyme replacement therapy for Pompe disease. Hum Vaccin Immunother 8:1459\u20131464. doi: 10.4161\/hv.21405","journal-title":"Hum Vaccin Immunother"},{"key":"464_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1089\/hum.2005.16.68","volume":"16","author":"KO Cresawn","year":"2005","unstructured":"Cresawn KO, Fraites TJ, Wasserfall C, Atkinson M, Lewis M, Porvasnik S, Liu C, Mah C, Byrne BJ (2005) Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid alpha-glucosidase in a model of glycogen storage disease type II. Hum Gene Ther 16:68\u201380. doi: 10.1089\/hum.2005.16.68","journal-title":"Hum Gene Ther"},{"key":"464_CR18","doi-asserted-by":"publisher","first-page":"9419","DOI":"10.1073\/pnas.0902534106","volume":"106","author":"LR DeRuisseau","year":"2009","unstructured":"DeRuisseau LR, Fuller DD, Qiu K, DeRuisseau KC, Donnelly WH Jr, Mah C, Reier PJ, Byrne BJ (2009) Neural deficits contribute to respiratory insufficiency in Pompe disease. Proc Natl Acad Sci U S A 106:9419\u20139424. doi: 10.1073\/pnas.0902534106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"464_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/hum.2013.021","volume":"25","author":"E Dirren","year":"2014","unstructured":"Dirren E, Towne CL, Setola V, Redmond DE Jr, Schneider BL, Aebischer P (2014) Intracerebroventricular injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord. Hum Gene Ther 25:109\u2013120. doi: 10.1089\/hum.2013.021","journal-title":"Hum Gene Ther"},{"key":"464_CR20","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1093\/hmg\/ddn290","volume":"17","author":"G Douillard-Guilloux","year":"2008","unstructured":"Douillard-Guilloux G, Raben N, Takikita S, Batista L, Caillaud C, Richard E (2008) Modulation of glycogen synthesis by RNA interference: towards a new therapeutic approach for glycogenosis type II. Hum Mol Genet 17:3876\u20133886. doi: 10.1093\/hmg\/ddn290","journal-title":"Hum Mol Genet"},{"key":"464_CR21","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.saa.2008.08.008","volume":"71","author":"I Dreissig","year":"2009","unstructured":"Dreissig I, Machill S, Salzer R, Krafft C (2009) Quantification of brain lipids by FTIR spectroscopy and partial least squares regression. Spectrochim Acta A Mol Biomol Spectrosc 71:2069\u20132075. doi: 10.1016\/j.saa.2008.08.008","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"464_CR22","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.gt.3300931","volume":"6","author":"SS Elliger","year":"1999","unstructured":"Elliger SS, Elliger CA, Aguilar CP, Raju NR, Watson GL (1999) Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector. Gene Ther 6:1175\u20131178. doi: 10.1038\/sj.gt.3300931","journal-title":"Gene Ther"},{"key":"464_CR23","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/mt.2013.96","volume":"21","author":"DJ Falk","year":"2013","unstructured":"Falk DJ, Mah CS, Soustek MS, Lee KZ, Elmallah MK, Cloutier DA, Fuller DD, Byrne BJ (2013) Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease. Mol Ther 21:1661\u20131667. doi: 10.1038\/mt.2013.96","journal-title":"Mol Ther"},{"key":"464_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/hmg\/ddu476","volume":"24","author":"DJ Falk","year":"2015","unstructured":"Falk DJ, Todd AG, Lee S, Soustek MS, ElMallah MK, Fuller DD, Notterpek L, Byrne BJ (2015) Peripheral nerve and neuromuscular junction pathology in Pompe disease. Hum Mol Genet 24:625\u2013636. doi: 10.1093\/hmg\/ddu476","journal-title":"Hum Mol Genet"},{"key":"464_CR25","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/gt.2011.130","volume":"19","author":"T Federici","year":"2012","unstructured":"Federici T, Taub JS, Baum GR, Gray SJ, Grieger JC, Matthews KA, Handy CR, Passini MA, Samulski RJ, Boulis NM (2012) Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs. Gene Ther 19:852\u2013859. doi: 10.1038\/gt.2011.130","journal-title":"Gene Ther"},{"key":"464_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.resp.2013.06.007","volume":"189","author":"DD Fuller","year":"2013","unstructured":"Fuller DD, ElMallah MK, Smith BK, Corti M, Lawson LA, Falk DJ, Byrne BJ (2013) The respiratory neuromuscular system in Pompe disease. Respir Physiol Neurobiol 189:241\u2013249. doi: 10.1016\/j.resp.2013.06.007","journal-title":"Respir Physiol Neurobiol"},{"key":"464_CR27","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/gt.2012.101","volume":"20","author":"SJ Gray","year":"2013","unstructured":"Gray SJ, Nagabhushan Kalburgi S, McCown TJ, Jude Samulski R (2013) Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther 20:450\u2013459. doi: 10.1038\/gt.2012.101","journal-title":"Gene Ther"},{"key":"464_CR28","doi-asserted-by":"publisher","unstructured":"Haurigot V, Marco S, Ribera A, Garcia M, Ruzo A, Villacampa P, Ayuso E, Anor S, Andaluz A, Pineda M, Garcia-Fructuoso G, Molas M, Maggioni L, Munoz S, Motas S, Ruberte J, Mingozzi F, Pumarola M, Bosch F (2013) Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy. J Clin Invest. doi: 10.1172\/JCI66778","DOI":"10.1172\/JCI66778"},{"key":"464_CR29","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.neuroimage.2009.09.053","volume":"49","author":"P Heraud","year":"2010","unstructured":"Heraud P, Caine S, Campanale N, Karnezis T, McNaughton D, Wood BR, Tobin MJ, Bernard CC (2010) Early detection of the chemical changes occurring during the induction and prevention of autoimmune-mediated demyelination detected by FT-IR imaging. NeuroImage 49:1180\u20131189. doi: 10.1016\/j.neuroimage.2009.09.053","journal-title":"NeuroImage"},{"key":"464_CR30","unstructured":"Hirschhorn R. RA (2001) Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. In: Graw-Hill NYM (ed) The metabolic and molecular bases of inherited disease. pp 2289-3420"},{"key":"464_CR31","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ymgme.2012.05.007","volume":"106","author":"LD Hobson-Webb","year":"2012","unstructured":"Hobson-Webb LD, Proia AD, Thurberg BL, Banugaria S, Prater SN, Kishnani PS (2012) Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature. Mol Genet Metab 106:462\u2013469. doi: 10.1016\/j.ymgme.2012.05.007","journal-title":"Mol Genet Metab"},{"key":"464_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/gt.2014.121","volume":"22","author":"J Hordeaux","year":"2015","unstructured":"Hordeaux J, Dubreil L, Deniaud J, Iacobelli F, Moreau S, Ledevin M, Le Guiner C, Blouin V, Le Duff J, Mendes-Madeira A, Rolling F, Cherel Y, Moullier P, Colle MA (2015) Efficient central nervous system AAVrh10-mediated intrathecal gene transfer in adult and neonate rats. Gene Ther 22:316\u2013324. doi: 10.1038\/gt.2014.121","journal-title":"Gene Ther"},{"key":"464_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ymthe.2005.08.006","volume":"13","author":"A Kiang","year":"2006","unstructured":"Kiang A, Hartman ZC, Liao S, Xu F, Serra D, Palmer DJ, Ng P, Amalfitano A (2006) Fully deleted adenovirus persistently expressing GAA accomplishes long-term skeletal muscle glycogen correction in tolerant and nontolerant GSD-II mice. Mol Ther 13:127\u2013134. doi: 10.1016\/j.ymthe.2005.08.006","journal-title":"Mol Ther"},{"key":"464_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.c.31324","volume":"160C","author":"PS Kishnani","year":"2012","unstructured":"Kishnani PS, Beckemeyer AA, Mendelsohn NJ (2012) The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management. Am J Med Genet C Semin Med Genet 160C:1\u20137. doi: 10.1002\/ajmg.c.31324","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"464_CR35","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1096\/fj.13-241893","volume":"28","author":"DD Koeberl","year":"2014","unstructured":"Koeberl DD, Austin S, Case LE, Smith EC, Buckley AF, Young SP, Bali D, Kishnani PS (2014) Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease. FASEB J 28:2171\u20132176. doi: 10.1096\/fj.13-241893","journal-title":"FASEB J"},{"key":"464_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ymgme.2011.11.005","volume":"105","author":"DD Koeberl","year":"2012","unstructured":"Koeberl DD, Li S, Dai J, Thurberg BL, Bali D, Kishnani PS (2012) \u03b22 agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease. Mol Genet Metab 105:221\u2013227. doi: 10.1016\/j.ymgme.2011.11.005","journal-title":"Mol Genet Metab"},{"key":"464_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fphys.2011.00031","volume":"2","author":"KZ Lee","year":"2011","unstructured":"Lee KZ, Qiu K, Sandhu MS, Elmallah MK, Falk DJ, Lane MA, Reier PJ, Byrne BJ, Fuller DD (2011) Hypoglossal neuropathology and respiratory activity in pompe mice. Front Physiol 2:31. doi: 10.3389\/fphys.2011.00031","journal-title":"Front Physiol"},{"key":"464_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1096\/fj.12-207472","volume":"27","author":"S Li","year":"2013","unstructured":"Li S, Sun B, Nilsson MI, Bird A, Tarnopolsky MA, Thurberg BL, Bali D, Koeberl DD (2013) Adjunctive beta2-agonists reverse neuromuscular involvement in murine Pompe disease. FASEB J 27:34\u201344. doi: 10.1096\/fj.12-207472","journal-title":"FASEB J"},{"key":"464_CR39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00687878","volume":"23","author":"JJ Martin","year":"1973","unstructured":"Martin JJ, de Barsy T, van Hoof F, Palladini G (1973) Pompe\u2019s disease: an inborn lysosomal disorder with storage of glycogen. A study of brain and striated muscle. Acta Neuropathol 23:229\u2013244","journal-title":"Acta Neuropathol"},{"key":"464_CR40","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1212\/WNL.57.5.906","volume":"57","author":"C Martini","year":"2001","unstructured":"Martini C, Ciana G, Benettoni A, Katouzian F, Severini GM, Bussani R, Bembi B (2001) Intractable fever and cortical neuronal glycogen storage in glycogenosis type 2. Neurology 57:906\u2013908","journal-title":"Neurology"},{"key":"464_CR41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/mt.2014.210","volume":"23","author":"K Meyer","year":"2015","unstructured":"Meyer K, Ferraiuolo L, Schmelzer L, Braun L, McGovern V, Likhite S, Michels O, Govoni A, Fitzgerald J, Morales P, Foust KD, Mendell JR, Burghes AH, Kaspar BK (2015) Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates. Mol Ther 23:477\u2013487. doi: 10.1038\/mt.2014.210","journal-title":"Mol Ther"},{"key":"464_CR42","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/hum.2014.011","volume":"25","author":"MA Passini","year":"2014","unstructured":"Passini MA, Bu J, Richards AM, Treleaven CM, Sullivan JA, O'Riordan CR, Scaria A, Kells AP, Samaranch L, San Sebastian W, Federici T, Fiandaca MS, Boulis NM, Bankiewicz KS, Shihabuddin LS, Cheng SH (2014) Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy. Hum Gene Ther 25:619\u2013630. doi: 10.1089\/hum.2014.011","journal-title":"Hum Gene Ther"},{"key":"464_CR43","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/mt.2013.239","volume":"22","author":"P Patel","year":"2014","unstructured":"Patel P, Kriz J, Gravel M, Soucy G, Bareil C, Gravel C, Julien JP (2014) Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis. Mol Ther 22:498\u2013510. doi: 10.1038\/mt.2013.239","journal-title":"Mol Ther"},{"key":"464_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/mt.2011.214","volume":"20","author":"K Qiu","year":"2012","unstructured":"Qiu K, Falk DJ, Reier PJ, Byrne BJ, Fuller DD (2012) Spinal delivery of AAV vector restores enzyme activity and increases ventilation in Pompe mice. Mol Ther 20:21\u201327. doi: 10.1038\/mt.2011.214","journal-title":"Mol Ther"},{"key":"464_CR45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","volume":"80","author":"N Raben","year":"2003","unstructured":"Raben N, Danon M, Gilbert AL, Dwivedi S, Collins B, Thurberg BL, Mattaliano RJ, Nagaraju K, Plotz PH (2003) Enzyme replacement therapy in the mouse model of Pompe disease. Mol Genet Metab 80:159\u2013169","journal-title":"Mol Genet Metab"},{"key":"464_CR46","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","volume":"273","author":"N Raben","year":"1998","unstructured":"Raben N, Nagaraju K, Lee E, Kessler P, Byrne B, Lee L, LaMarca M, King C, Ward J, Sauer B, Plotz P (1998) Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem 273:19086\u201319092","journal-title":"J Biol Chem"},{"key":"464_CR47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","volume":"76","author":"JE Rabinowitz","year":"2002","unstructured":"Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X, Samulski RJ (2002) Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 76:791\u2013801","journal-title":"J Virol"},{"key":"464_CR48","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10545-010-9209-0","volume":"33","author":"M Rohrbach","year":"2010","unstructured":"Rohrbach M, Klein A, Kohli-Wiesner A, Veraguth D, Scheer I, Balmer C, Lauener R, Baumgartner MR (2010) CRIM-negative infantile Pompe disease: 42-month treatment outcome. J Inherit Metab Dis 33:751\u2013757. doi: 10.1007\/s10545-010-9209-0","journal-title":"J Inherit Metab Dis"},{"key":"464_CR49","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1089\/hum.2013.005","volume":"24","author":"L Samaranch","year":"2013","unstructured":"Samaranch L, Salegio EA, San Sebastian W, Kells AP, Bringas JR, Forsayeth J, Bankiewicz KS (2013) Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates. Hum Gene Ther 24:526\u2013532. doi: 10.1089\/hum.2013.005","journal-title":"Hum Gene Ther"},{"key":"464_CR50","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/hum.2011.200","volume":"23","author":"L Samaranch","year":"2012","unstructured":"Samaranch L, Salegio EA, San Sebastian W, Kells AP, Foust KD, Bringas JR, Lamarre C, Forsayeth J, Kaspar BK, Bankiewicz KS (2012) Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther 23:382\u2013389. doi: 10.1089\/hum.2011.200","journal-title":"Hum Gene Ther"},{"key":"464_CR51","doi-asserted-by":"crossref","unstructured":"Severcan F. HPI (2012) Vibrational Spectroscopy in Diagnosis and Screening. In: Advances in Biomedical Spectroscopy, vol 6","DOI":"10.3233\/978-1-61499-059-8-1"},{"key":"464_CR52","doi-asserted-by":"publisher","first-page":"10408","DOI":"10.1128\/JVI.01155-12","volume":"86","author":"S Shen","year":"2012","unstructured":"Shen S, Bryant KD, Sun J, Brown SM, Troupes A, Pulicherla N, Asokan A (2012) Glycan binding avidity determines the systemic fate of adeno-associated virus type 9. J Virol 86:10408\u201310417. doi: 10.1128\/JVI.01155-12","journal-title":"J Virol"},{"key":"464_CR53","doi-asserted-by":"publisher","first-page":"28814","DOI":"10.1074\/jbc.M113.482380","volume":"288","author":"S Shen","year":"2013","unstructured":"Shen S, Horowitz ED, Troupes AN, Brown SM, Pulicherla N, Samulski RJ, Agbandje-McKenna M, Asokan A (2013) Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency. J Biol Chem 288:28814\u201328823. doi: 10.1074\/jbc.M113.482380","journal-title":"J Biol Chem"},{"key":"464_CR54","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/NEN.0b013e3181815994","volume":"67","author":"RL Sidman","year":"2008","unstructured":"Sidman RL, Taksir T, Fidler J, Zhao M, Dodge JC, Passini MA, Raben N, Thurberg BL, Cheng SH, Shihabuddin LS (2008) Temporal neuropathologic and behavioral phenotype of 6neo\/6neo Pompe disease mice. J Neuropathol Exp Neurol 67:803\u2013818. doi: 10.1097\/NEN.0b013e3181815994","journal-title":"J Neuropathol Exp Neurol"},{"key":"464_CR55","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1089\/hum.2012.250","volume":"24","author":"BK Smith","year":"2013","unstructured":"Smith BK, Collins SW, Conlon TJ, Mah CS, Lawson LA, Martin AD, Fuller DD, Cleaver BD, Clement N, Phillips D, Islam S, Dobjia N, Byrne BJ (2013) Phase I\/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes. Hum Gene Ther 24:630\u2013640. doi: 10.1089\/hum.2012.250","journal-title":"Hum Gene Ther"},{"key":"464_CR56","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.expneurol.2016.07.013","volume":"287","author":"BK Smith","year":"2017","unstructured":"Smith BK, Martin AD, Lawson LA, Vernot V, Marcus J, Islam S, Shafi N, Corti M, Collins SW, Byrne BJ (2017) Inspiratory muscle conditioning exercise and diaphragm gene therapy in Pompe disease: clinical evidence of respiratory plasticity. Exp Neurol 287:216\u2013224. doi: 10.1016\/j.expneurol.2016.07.013","journal-title":"Exp Neurol"},{"key":"464_CR57","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1212\/WNL.0b013e31828b8af0","volume":"80","author":"GA Spiridigliozzi","year":"2013","unstructured":"Spiridigliozzi GA, Heller JH, Kishnani PS, Van der Ploeg AT, Ebbink BJ, Aarsen FK, van Gelder CM, Van den Hout JM (2013) Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy. Neurology 80:1173. doi: 10.1212\/WNL.0b013e31828b8af0","journal-title":"Neurology"},{"key":"464_CR58","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/mt.2008.133","volume":"16","author":"B Sun","year":"2008","unstructured":"Sun B, Young SP, Li P, Di C, Brown T, Salva MZ, Li S, Bird A, Yan Z, Auten R, Hauschka SD, Koeberl DD (2008) Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy. Mol Ther 16:1366\u20131371. doi: 10.1038\/mt.2008.133","journal-title":"Mol Ther"},{"key":"464_CR59","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ymthe.2006.08.001","volume":"14","author":"B Sun","year":"2006","unstructured":"Sun B, Zhang H, Benjamin DK Jr, Brown T, Bird A, Young SP, McVie-Wylie A, Chen YT, Koeberl DD (2006) Enhanced efficacy of an AAV vector encoding chimeric, highly secreted acid alpha-glucosidase in glycogen storage disease type II. Mol Ther 14:822\u2013830. doi: 10.1016\/j.ymthe.2006.08.001","journal-title":"Mol Ther"},{"key":"464_CR60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ymthe.2004.10.004","volume":"11","author":"B Sun","year":"2005","unstructured":"Sun B, Zhang H, Franco LM, Young SP, Schneider A, Bird A, Amalfitano A, Chen YT, Koeberl DD (2005) Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II. Mol Ther 11:57\u201365. doi: 10.1016\/j.ymthe.2004.10.004","journal-title":"Mol Ther"},{"key":"464_CR61","first-page":"379","volume":"27","author":"YT Teng","year":"2004","unstructured":"Teng YT, Su WJ, Hou JW, Huang SF (2004) Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings. Chang Gung Med J 27:379\u2013384","journal-title":"Chang Gung Med J"},{"key":"464_CR62","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/labinvest.3700484","volume":"86","author":"BL Thurberg","year":"2006","unstructured":"Thurberg BL, Lynch Maloney C, Vaccaro C, Afonso K, Tsai AC, Bossen E, Kishnani PS, O\u2019Callaghan M (2006) Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Investig 86:1208\u20131220. doi: 10.1038\/labinvest.3700484","journal-title":"Lab Investig"},{"key":"464_CR63","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ana.24433","volume":"78","author":"AG Todd","year":"2015","unstructured":"Todd AG, McElroy JA, Grange RW, Fuller DD, Walter GA, Byrne BJ, Falk DJ (2015) Correcting neuromuscular deficits with gene therapy in Pompe disease. Ann Neurol 78:222\u2013234. doi: 10.1002\/ana.24433","journal-title":"Ann Neurol"},{"key":"464_CR64","doi-asserted-by":"publisher","first-page":"02016","DOI":"10.1152\/physiolgenomics.00075.2016","volume":"00075","author":"SM Turner","year":"2016","unstructured":"Turner SM, Falk DJ, Byrne BJ, Fuller DD (2016) Transcriptome assessment of the Pompe (Gaa\u2212\/\u2212) mouse spinal cord indicates widespread neuropathology. Physiol Genomics 00075:02016. doi: 10.1152\/physiolgenomics.00075.2016","journal-title":"Physiol Genomics"},{"key":"464_CR65","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.resp.2016.02.007","volume":"227","author":"SM Turner","year":"2016","unstructured":"Turner SM, Hoyt AK, ElMallah MK, Falk DJ, Byrne BJ, Fuller DD (2016) Neuropathology in respiratory-related motoneurons in young Pompe (Gaa(\u2212\/\u2212)) mice. Respir Physiol Neurobiol 227:48\u201355. doi: 10.1016\/j.resp.2016.02.007","journal-title":"Respir Physiol Neurobiol"},{"key":"464_CR66","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10545-014-9707-6","volume":"38","author":"CM Gelder van","year":"2015","unstructured":"van Gelder CM, Hoogeveen-Westerveld M, Kroos MA, Plug I, van der Ploeg AT, Reuser AJ (2015) Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease. J Inherit Metab Dis 38:305\u2013314. doi: 10.1007\/s10545-014-9707-6","journal-title":"J Inherit Metab Dis"},{"key":"464_CR67","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10545-011-9404-7","volume":"35","author":"CM Gelder van","year":"2012","unstructured":"van Gelder CM, van Capelle CI, Ebbink BJ, Moor-van Nugteren I, van den Hout JM, Hakkesteegt MM, van Doorn PA, de Coo IF, Reuser AJ, de Gier HH, van der Ploeg AT (2012) Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy. J Inherit Metab Dis 35:505\u2013511. doi: 10.1007\/s10545-011-9404-7","journal-title":"J Inherit Metab Dis"},{"key":"464_CR68","doi-asserted-by":"publisher","first-page":"14018","DOI":"10.1038\/mtm.2014.18","volume":"1","author":"G Wang","year":"2014","unstructured":"Wang G, Young SP, Bali D, Hutt J, Li S, Benson J, Koeberl DD (2014) Assessment of toxicity and biodistribution of recombinant AAV8 vector-mediated immunomodulatory gene therapy in mice with Pompe disease. Mol Ther Methods Clin Dev 1:14018. doi: 10.1038\/mtm.2014.18","journal-title":"Mol Ther Methods Clin Dev"},{"key":"464_CR69","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/hmg\/ddt454","volume":"23","author":"H Wang","year":"2014","unstructured":"Wang H, Yang B, Qiu L, Yang C, Kramer J, Su Q, Guo Y, Brown RH Jr, Gao G, Xu Z (2014) Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis. Hum Mol Genet 23:668\u2013681. doi: 10.1093\/hmg\/ddt454","journal-title":"Hum Mol Genet"},{"key":"464_CR70","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/sj.gt.3302735","volume":"13","author":"G Watson","year":"2006","unstructured":"Watson G, Bastacky J, Belichenko P, Buddhikot M, Jungles S, Vellard M, Mobley WC, Kakkis E (2006) Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice. Gene Ther 13:917\u2013925. doi: 10.1038\/sj.gt.3302735","journal-title":"Gene Ther"},{"key":"464_CR71","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/sj.gt.3302314","volume":"11","author":"F Xu","year":"2004","unstructured":"Xu F, Ding E, Liao SX, Migone F, Dai J, Schneider A, Serra D, Chen YT, Amalfitano A (2004) Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model. Gene Ther 11:1590\u20131598. doi: 10.1038\/sj.gt.3302314","journal-title":"Gene Ther"},{"key":"464_CR72","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.brainres.2006.01.107","volume":"1091","author":"X Zhou","year":"2006","unstructured":"Zhou X, Jen PH, Seburn KL, Frankel WN, Zheng QY (2006) Auditory brainstem responses in 10 inbred strains of mice. Brain Res 1091:16\u201326. doi: 10.1016\/j.brainres.2006.01.107","journal-title":"Brain Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-017-0464-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T15:57:41Z","timestamp":1750867061000},"score":1,"resource":{"primary":{"URL":"http:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-017-0464-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,6]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["464"],"URL":"https:\/\/doi.org\/10.1186\/s40478-017-0464-2","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,6]]},"article-number":"66"}}